Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma

NCT03281551 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia
B-cell Lymphoma

Interventions

DRUG: PZ01 CAR-T cells

Sponsor

Pinze Lifetechnology Co. Ltd.

Collaborators

[object Object]
[object Object]